Anzeige
Mehr »
Login
Montag, 13.07.2020 Börsentäglich über 12.000 News von 632 internationalen Medien
Die News der News! Mehrere Hundert Prozent Kursgewinn am Montag?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NBNG ISIN: US0231112063 Ticker-Symbol: EH3A 
Tradegate
10.07.20
10:31 Uhr
5,850 Euro
-0,050
-0,85 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AMARIN CORPORATION PLC ADR Chart 1 Jahr
5-Tage-Chart
AMARIN CORPORATION PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
5,8506,00012.07.
5,9006,00010.07.

Aktuelle News zur AMARIN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
AMARIN Aktie jetzt für 0€ handeln
MiHere's Why Amarin Tumbled 67.7% in the First Half of 202030
17.06.Amarin Analysts Say Vascepa Patent Settlement Not A Stock Mover, With 'Little Readthrough For Pending Patent Appeal'59
17.06.A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success34
17.06.AMRN, STWD among premarket gainers12
17.06.The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked17
17.06.AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact953INDIANAPOLIS (dpa-AFX) - Today's Daily Dose brings you news about Amarin's settlement agreement with Apotex; Annovis Bio's progress in its Alzheimer's drug development program; IDEAYA's deal...
► Artikel lesen
17.06.BRIEF-Amarin Announces Patent Litigation Settlement Agreement With Apotex23
16.06.AMARIN CORP PLC - 8-K, Current Report6
16.06.Amarin settles with Apotex, delays generic Vascepa until 202913
16.06.Amarin Corporation plc: Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc.9
15.06.Amarin Corporation plc: VASCEPA (icosapent ethyl) Shows Significant Cardiovascular Risk Reduction in People with Diabetes in Prespecified and Post Hoc ...27
08.06.Amarin: Dr. Bhatt's Important New Report Suggests Fresh Angle To The Appeal58
01.06.Amarin: Some Investment Strategies For 202057
01.06.Amarin plans to increase Vascepa awareness20
01.06.BRIEF-Amarin Plans To Increase Vascepa Promotion And Education14
01.06.Amarin Corporation plc: Amarin Plans to Increase VASCEPA (icosapent ethyl) Promotion and Education13
01.06.Amarin Continues Its Fight Against Generic Vascepa23
22.05.FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules67
22.05.Generic Threat To Amarin's Vascepa Overrides Positive Sentiment On Coronavirus Announcement22
22.05.Amarin's Vascepa loses one more shield with Hikma's generic approval30
Seite:  Weiter >>
176 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,11